Key | % Net Assets |
---|---|
![]() |
7.0% |
![]() |
5.6% |
![]() |
5.2% |
![]() |
4.9% |
![]() |
77.3% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 7.0% |
BP | 5.6% |
BG | 5.2% |
BAE Systems | 4.9% |
BG | 4.5% |
Rentokil Initial | 4.4% |
AstraZeneca | 4.3% |
Imperial Tobacco | 4.1% |
Legal & General | 3.9% |
Roche | 3.4% |
No asset data available.
Date | 14-Feb-2025 |
---|---|
NAV | 547.72p |
Currency | GBP |
Change | 1.62p |
% | 0.30% |
YTD change | 20.84p |
YTD % | 3.96% |
Fund Inception | 12/06/1987 |
---|---|
Fund Manager | Ed Burke |
TER | 1.69 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.66% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.10 |
You are here: research